Q/C Technologies, Inc. Equity Method Investment, Ownership Percentage
Q/C Technologies, Inc. (QCLS) had Equity Method Investment, Ownership Percentage of 19.90% as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes › Investments
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2017-04-11
- 2016-09-30: Equity Method Investment, Ownership Percentage 19.90%.
- 2016-06-30: Equity Method Investment, Ownership Percentage 19.90%.
- 2016-03-31: Equity Method Investment, Ownership Percentage 19.90%.
- 2015-12-31: Equity Method Investment, Ownership Percentage 19.90%.
| Period end | Equity Method Investment, Ownership Percentage | Equity Method Investment, Ownership Percentage as first filed |
|---|---|---|
| 2016-09-30 | 19.90% 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 19.90% 10-Q · filed 2016-08-11 | |
| 2016-03-31 | 19.90% 10-Q · filed 2016-05-12 | |
| 2015-12-31 | 19.90% 10-K · filed 2016-03-30 | |
| 2015-09-30 | 19.90% 10-Q · filed 2015-11-13 | |
| 2015-06-30 | 19.90% 10-Q · filed 2015-08-18 | |
| 2015-03-31 | 19.90% 10-Q · filed 2015-05-14 | |
| 2015-03-09 | 19.90% 10-K · filed 2017-04-11 | |
| 2014-12-31 | 28.00% 10-K · filed 2016-03-30 | 20.00% 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |